DiscoverEmergency Medical MinuteEpisode 926: Supraventricular Tachycardia
Episode 926: Supraventricular Tachycardia

Episode 926: Supraventricular Tachycardia

Update: 2024-10-21
Share

Description

Contributor: Taylor Lynch MD

  • Supraventricular tachycardias (SVTs) arise above the bundle of His

    • The term SVT includes AV nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), atrial tachycardia, atrial fibrillation, atrial flutter, and multifocal atrial tachycardia 

  • AVNRT is the most common form of SVT

    • Paroxysmal

    • Spontaneous or provoked by exertion, coffee, alcohol, or thyroid disease

    • More common in women (3:1 women:men ratio)

    • HR 160-240

    • Narrow complex with a normal QRS

  • Unstable patients receive synchronized cardioversion at 0.5-1 J/kg

  • Valsalva maneuver is attempted before pharmaceutical interventions

    • Increases vagal tone at the AV node to slow conduction and prolongs its refractory period to normalize the conduction

    • Traditionally, patients are asked to bear down, but this only works in 17% of patients

    • REVERT trial assessed a modified valsalva that worked in 43% of patients

  • Adenosine

    • Slows conduction at the AV node by activating potassium channels and inhibiting calcium influx

    • Extremely uncomfortable for most patients

    • Not commonly used anymore

  • Nondihydropyridine calcium-channel blockers are preferred

    • A 2009 RCT investigated low-infusion CCBs compared with adenosine bolus

    • The study found a conversion rate of 98% in the CCB group vs. adenosine group at 86.5%

    • The main adverse effect of CCB is hypotension, which a slow infusion rate can mitigate

    • Diltiazem dose is 0.25 mg/kg/2min and repeat at 0.35 mg/kg/15 minutes or slow infusion at 2.5 mg/min up to a conversion or 50 mg total

References

  1. 1. Appelboam A, Reuben A, Mann C, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): A randomised controlled trial. Lancet. 2015;386(10005):1747-1753. doi:10.1016/S0140-6736(15)61485-4

  2. Belz MK, Stambler BS, Wood MA, Pherson C, Ellenbogen KA. Effects of enhanced parasympathetic tone on atrioventricular nodal conduction during atrioventricular nodal reentrant tachycardia. Am J Cardiol. 1997;80(7):878-882. doi:10.1016/s0002-9149(97)00539-0

  3. Lim SH, Anantharaman V, Teo WS, Chan YH. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia. Resuscitation. 2009;80(5):523-528. doi:10.1016/j.resuscitation.2009.01.017

  4. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published correction appears in Circulation. 2016 Sep 13;134(11):e234-5. doi: 10.1161/CIR.0000000000000448]. Circulation. 2016;133(14):e506-e574. doi:10.1161/CIR.0000000000000311

Summarized & Edited by Jorge Chalit, OMS3

Donate: https://emergencymedicalminute.org/donate/

 

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 926: Supraventricular Tachycardia

Episode 926: Supraventricular Tachycardia